Repligen Corporation (NASDAQ:RGEN) Delivers Strong 2Q Sales Of Protein A Affinity Ligands

Boston, MA 08/11/2014 (wallstreetpr) – Life science company Repligen Corporation (NASDAQ:RGEN) delivered strong sales and earnings number for the second quarter driven by robust sales of protein A affinity ligands apart from higher demand for its chromatography products. As a result, the company’s bottom line came in more than the Street analysts’ estimations. CEO Comments […]